Michael W. Heslop
Nessuna posizione attualmente
Profilo
Michael W.
Heslop worked as a Marketing Director at Glaxo Wellcome, Inc. from 1996 to 1998.
He then worked as Vice President of Business Development at Scriptgen Pharmaceuticals, Inc. from 1998 to 2000.
From 2000 to 2011, he worked at Genzyme Corp.
as Senior Vice President and GM of Biosurgical Specialties.
In 2012 and 2013, he worked at Lantheus Medical Imaging, Inc. as Vice President of International.
Heslop received his undergraduate degree from McGill University and his MBA from Concordia University.
Precedenti posizioni note di Michael W. Heslop
| Società | Posizione | Fine |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2011 |
Scriptgen Pharmaceuticals, Inc.
 Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Scriptgen Pharmaceuticals, Inc. discovers and develops small molecule drugs. It develops antifungal and antibacterial drugs, as well as compounds for treatment of hepatitis. The company is headquartered in Medford, MA | Corporate Officer/Principal | 01/01/2000 |
| Glaxo Wellcome, Inc. | Sales & Marketing | 01/01/1998 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Corporate Officer/Principal | - |
Formazione di Michael W. Heslop
| McGill University | Undergraduate Degree |
| Concordia University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Scriptgen Pharmaceuticals, Inc. discovers and develops small molecule drugs. It develops antifungal and antibacterial drugs, as well as compounds for treatment of hepatitis. The company is headquartered in Medford, MA | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
- Borsa valori
- Insiders
- Michael W. Heslop
